An observational study in Intertrochanteric Femur Fracture, Hip Fracture Surgeries and Geriatric Anesthesia, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Saglik Bilimleri Universitesi · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 78 studies in Hip Fractures with a site in Turkey — 14 open to participants now, 18 under way, none of them phase 3. Hip Fractures · Turkey.
Among the 78 studies in Hip Fractures with a site in Turkey, this one is the 3rd largest by enrollment of the 40 observational ones that give a count, is one of 7 that started in 2021, is one of 40 observational ones, and was the 72nd registered.
843 studies on the registry are indexed under Hip Fractures; 166 are open to participants now.
Browse Hip Fractures studies →14 of the 78 studies in Hip Fractures with a site in Turkey are open now. Recruiting first, the newest first:
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Sites in Turkey
Ages 65+
Taksim Egitim ve Arastirma Hastanesi · Sites in Turkey
Ages 50+
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Sites in Turkey
Ages 18+
Trakya University · Sites in Turkey
Ages 60+
Duzce University · Sites in Turkey
Ages 65+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 104 Hip Fractures studies recruiting now, 82 (79%) set no upper age limit and 6 (6%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
78 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 7 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 233 is above the median of 149 across 280 observational studies indexed under Hip Fractures.
Median enrollment 67 across the 38 interventional studies, 98 across the 40 observational. Of the 55 that completed or were terminated, 2 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 78 have an industry lead sponsor. The 10 most frequent:
Saglik Bilimleri Universitesi is the lead sponsor of 458 studies on the registry; 124 are open to participants now.
Saglik Bilimleri Universitesi has 2 studies filed under Hip Fractures — fewer than ten, so there is no comparison to draw.
7 of the studies in Hip Fractures with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07717463Taksim Egitim ve Arastirma HastanesiPericapsular Nerve Group Block Versus Femoral Nerve Block Study | 2026-12-14 |
| NCT07612761Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalComparison of Meta-PENG and Suprainguinal Fascia Iliaca Plane Block in Hip Fractures | 2026-12-31 |
| NCT07676734Başakşehir Çam & Sakura City HospitalComparison of Three Analgesic Strategies for Hip Fracture Surgery | 2027-01 |
| NCT07463352Duzce UniversityPreoperative Oral Nutrition And Outcomes In Frail Elderly Patients With Femur Fractures | 2027-01-01 |
| NCT07481188Trakya UniversityFrailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery | 2027-03-15 |
Add all 7 to your calendar (.ics) → With an account.
Among the 78 studies in Hip Fractures with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This retrospective observational cohort study aims to evaluate the association between preoperative and postoperative inflammatory indices and early postoperative outcomes in geriatric patients undergoing proximal femoral nailing (PFN) for intertrochanteric femur fractures. The primary outcome of the study is 30-day mortality, while the secondary outcome is intensive care unit (ICU) length of stay. Various inflammatory biomarkers derived from routine laboratory parameters, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), immune-inflammatory prognostic index (IPI), aggregate index of systemic inflammation (AIS), and RDW-to-albumin ratio (RAR), will be analyzed to investigate their prognostic value in the acute postoperative period. The study seeks to identify simple and readily accessible biomarkers that may contribute to early risk stratification and perioperative management in elderly hip fracture patients.
Hip fractures are associated with substantial morbidity and mortality in the geriatric population. Intertrochanteric femur fractures, in particular, frequently require surgical stabilization with proximal femoral nailing (PFN). Despite advances in perioperative care, early postoperative mortality rates and intensive care utilization remain high in elderly patients undergoing PFN surgery. Identifying reliable biomarkers that reflect the acute systemic inflammatory response to surgical trauma may improve perioperative risk stratification and postoperative management.
In recent years, several hematologic inflammatory indices derived from routine laboratory parameters have emerged as potential prognostic markers in different clinical settings. These include neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), aggregate index of systemic inflammation (AIS), immune-inflammatory prognostic index (IPI), and red cell distribution width-to-albumin ratio (RAR). However, data regarding the prognostic significance of these inflammatory indices in geriatric orthopedic trauma patients remain limited.
This retrospective observational cohort study evaluates the association between preoperative and postoperative inflammatory indices and early postoperative outcomes in geriatric patients undergoing PFN surgery for intertrochanteric femur fractures. Electronic medical records of eligible patients aged 65 years and older will be reviewed retrospectively. Demographic characteristics, comorbidities, perioperative laboratory findings, inflammatory indices, 30-day mortality, and intensive care unit (ICU) length of stay will be analyzed.
The primary outcome of the study is 30-day mortality. The secondary outcome is ICU length of stay. The study aims to determine whether inflammatory indices, particularly RDW-to-albumin ratio (RAR), are independently associated with early mortality and prolonged ICU stay in the acute postoperative period. The findings may contribute to the identification of simple and cost-effective biomarkers for early risk assessment in geriatric hip fracture patients.
Geriatric patients aged 65 years and older who underwent proximal femoral nailing (PFN) surgery for intertrochanteric femur fractures at a tertiary referral center were retrospectively evaluated. The study population consisted of patients with available perioperative laboratory data, 30-day mortality information, and intensive care unit follow-up records.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Geriatric patients aged 65 years and older who underwent proximal femoral nailing (PFN) surgery for intertrochanteric femur fractures and were retrospectively evaluated for inflammatory indices, 30-day mortality, and intensive care unit length of stay.
30-Day Mortality
Evaluation of all-cause mortality occurring within the first 30 postoperative days in geriatric patients undergoing proximal femoral nailing surgery.
Time frame: Within 30 days after surgery
Intensive Care Unit Length of Stay
ICU stay duration in days
Time frame: 30 days
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jan 2021 to primary completion in Dec 2025, 59 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Jun 2026 → Dec 2025 and completion Jun 2026 → Dec 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Saglik Bilimleri Universitesi →